Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-08-10 12:21 pm Sale |
2021-08-10 | 13G | Sarepta Therapeutics, Inc. SRPT |
Capital Research Global Investors | 3,842,491 4.800% |
-4,181,639 (-52.11%) |
Filing History |
| 2021-02-16 11:40 am Sale |
2020-12-31 | 13G | Sarepta Therapeutics, Inc. SRPT |
SANDS CAPITAL MANAGEMENT, LLC | 977,131 1.240% |
-3,580,368 (-78.56%) |
Filing History |
| 2021-02-10 12:30 pm Purchase |
2021-02-10 | 13G | Sarepta Therapeutics, Inc. SRPT |
Capital Research Global Investors | 8,024,130 10.200% |
287,382 (+3.71%) |
Filing History |
| 2021-02-10 12:26 pm Purchase |
2021-02-10 | 13G | Sarepta Therapeutics, Inc. SRPT |
Capital Research Global Investors | 7,736,748 9.800% |
7,736,748 (New Position) |
Filing History |
| 2021-02-10 11:52 am Purchase |
2020-12-31 | 13G | Sarepta Therapeutics, Inc. SRPT |
The Vanguard Group | 7,217,259 9.150% |
832,471 (+13.04%) |
Filing History |
| 2021-02-08 10:31 am Sale |
2021-02-05 | 13G | Sarepta Therapeutics, Inc. SRPT |
FMR LLC | 6,115,228 7.741% |
-2,232,756 (-26.75%) |
Filing History |
| 2021-02-01 08:23 am Purchase |
2020-12-31 | 13G | Sarepta Therapeutics, Inc. SRPT |
BlackRock Inc. BLK |
5,379,215 6.800% |
738,930 (+15.92%) |
Filing History |